Keywords: CPRA; calculated panel reactive antibody; CPRAd; calculated panel reactive antibody with decimals; HLA; human leukocyte antigen; LCD; likelihood of finding a compatible donor; UNOS; United Network for Organ Sharing; Histocompatibility; Calculated panel re
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: DSA; donor-specific HLA antibody; CPRA; Calculated Panel Reactive Antibody; FC-XM; flow cytometric crossmatch; MFI; mean fluorescence intensity; KAS; kidney allocation system; Kidney transplantation; Kidney allocation system (KAS); HLA sensitization; Unac
Keywords: UNOS; United Network for Organ Sharing; KAS; kidney allocation system; cPRA; calculated panel reactive antibody; DSA; donor specific antibodies; CDC; complement dependent cytotoxicity; MFI; mean fluorescence intensity; Kidney transplantation; Kidney alloc
Keywords: CIT; cold ischemia time; cPRA; calculated panel-reactive antibody; DGF; delayed graft function; ECD; expanded criteria donor; EPTS; estimated posttransplant survival; ESRD; end-stage renal disease; HLA; human leukocyte antigen; KAS; kidney allocation syst
Keywords: Kidney transplantation; Human leukocyte antigen; CPRA;
Keywords: cPRA; calculated panel reactive antibody; CXM; crossmatch; FCXM; flow cytometric crossmatch; KAS; revised kidney allocation system; MCS; mean channel shift; MFI; mean fluorescence intensity; PRA; panel reactive antibody; SPI; solid phase immunoassay; VCXM
Keywords: donor allocation; heart transplantation; primary graft dysfunction; rejection; sensitization; survival; ACR; acute cellular rejection; AMR; antibody-mediated rejection; BiVAD; biventricular assist device; CIN; calcineurin inhibitor; CPRA; calculated panel
Keywords: CFS; cubic feet per second; Chl a; chlorophyll a; CPRA; Coastal Protection and Restoration Authority; CPUE; catch per unit effort; EwE; Ecopath with Ecosim software; FIMP; Fisheries Independent Monitoring Program; FWOA; future without action; LDWF; Louisi
Keywords: heart transplant; C1q; solid phase antibody testing; CDC; CPRA; unacceptable antigen;
Keywords: AMR; antibody-mediated rejection; RBCT; red blood cell transfusion; cPRA; calculated panel reactive antibody; DSA; donor specific antibodies; DGF; delayed graft function; BPAR; biopsy proven acute rejection; MFI; mean fluorescence intensity; SAB; single a
Fatal accelerated rejection with a prominent natural killer cell infiltrate in a heart transplant recipient with peripartum cardiomyopathy
Keywords: Transplantation; Rejection; NK cells; ACR; acute cellular rejection; AMR; antibody-mediated rejection; CMV; cytomegalovirus; CPRA; calculated panel reactive antibody; DSA; donor specific antibody; Ig; immunoglobulins; ISHLT; International Society for Hear
Cln5 is secreted and functions as a glycoside hydrolase in Dictyostelium
Keywords: AprA; autocrine proliferation repressor A; CadA; calcium-dependent cell adhesion molecule A; CDC48; cell division cycle protein 48; CfaD; counting factor-associated protein D; CLN5; ceroid lipofuscinosis neuronal 5; CM; conditioned media; CprA; cysteine p
The new kidney allocation system does not equally advantage all very high cPRA candidates - A single center analysis
Keywords: cPRA; calculated panel reactive antibody; EPTS; estimated post-transplant survival; KAS; kidney allocation system; KDPI; kidney donor profile index; OPTN; Organ Procurement and Transplant Network; UAs; unacceptable antigens; UNOS; United Network for Organ
HLA compatibility assessment and management of highly sensitized patients under the new kidney allocation system (KAS): A 2016 status report from twelve HLA laboratories across the U.S.
Keywords: cPRA; calculated panel reactive antibody; CDC; complement dependent cytotoxicity; XM; crossmatch; DD; deceased donor; DSA; donor specific antibodies; KAS; kidney allocation system; MFI; mean fluorescence intensity; PCR; polymerase chain reaction; RT-PCR;
New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist
Keywords: ACR; acute cellular rejection; AMR; antibody mediated rejection; ATN; acute tubular necrosis; cPRA; calculated panel reactive antibody; DGF; delayed graft function; DSA; donor specific antibody; KAS; Kidney Allocation System; EPTS; estimated post transpla
Understanding solid-phase HLA antibody assays and the value of MFI
Keywords: MFI; mean fluorescence intensity; HLA; human leukocyte antigen; SAB; single antigen bead; DSA; donor-specific antibody; AMR; antibody mediated rejection; cPRA; calculated PRA; EDTA; Ethylenediaminetetraacetic acid; DTT; Dithiothreitol; PE; phycoerythrin;
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy
Keywords: endothelial function; heart failure; idiopathic dilated cardiomyopathy; immune biomarker; stem cell therapy; 6MWT; 6-min walk test; allo; allogeneic; auto; autologous; CI; confidence interval; cPRA; calculated panel reactive antibody; EDV; end-diastolic v
CPRA for allocation of kidneys in the US: More candidates ≥98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patients
Keywords: CPRA; HLA antibodies; Sensitization; Crossmatch; Kidney transplant
HLA-A2 reactive antibodies in a patient who types as HLA-A2: The importance of high resolution typing and epitope-based antibody analysis
Keywords: cPRA; calculated panel reactive antibody; MFI; mean fluorescence intensity; HLA; Epitope; Antibody analysis;
Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death
Keywords: AMR; Antibody-mediated Rejection; CDC; Complement Dependant Cytotoxicity; cPRA; Calculated Panel Reactive Antibody; DSA; Donor Specific Antibodies; HB-MFI; Highest bead MFI; DGF; Delayed Graft Function; BPAR; Biopsy Proven Acute Rejection; MFI; Mean Fluor